The UK competition watchdog the Office for Fair Trading has fined Reckitt Benckiser £10.2 million ($16 million) after the company admitted abusing its dominant position when supplying heartburn medicines to the National Health Service
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Abbott winning another round against Sinocare and Menarini, and 'long arm' clarification on the UK's position within the UPC, were also among major developments
Executive chair Matt Dixon, who reveals a new associate hire, says the firm wants to offer a realistic pathway to partnership while avoiding the ‘corporate machine’ route